Clinical Trial: Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07835152) titled 'Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults' on Sept. 17.

Brief Summary: The purpose of this study is to evaluate the long-term safety of BR005-036C tablets in the acute treatment of migraines

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Migraine, With or Without Aura

Intervention: DRUG: BR005-036C

Oral tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Brise Pharmaceuticals Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....